Contact with stimulated T cells up-regulates expression of peptidylarginine deiminase 2 and 4 by human monocytes

European Cytokine Network

Volumn 23, Issue 2, 2012, Pages 36-44

  Ferrari Lacraz, Sylvie ^a   Sebbag, Mireille ^b,c,d   Chicheportiche, Rachel ^a   Foulquier, Céline ^c,d   Serre, Guy ^b,c,d,e   Dayer, Jean Michel ^f  

^a University Hospital and Faculty of Medicine   (Switzerland)

^b CNRS   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d France   (France)

^e CHU PURPAN   (France)

^f UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Monocytes; Peptidylarginine deiminase (PAD); Rheumatoid arthritis; Synovial cells; T cell contact

Indexed keywords

BETA INTERFERON; INTERLEUKIN 1BETA; MESSENGER RNA; PROTEIN ARGININE DEIMINASE; PROTEIN ARGININE DEIMINASE 2; PROTEIN ARGININE DEIMINASE 4; UNCLASSIFIED DRUG;

ARTICLE; CELL INTERACTION; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MACROPHAGE ACTIVATION; MOLECULAR INTERACTION; MONOCYTE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CELLS, CULTURED; FIBROBLASTS; HUMANS; HYDROLASES; INTERFERON-BETA; INTERLEUKIN-1BETA; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MACROPHAGES; MONOCYTES; RNA, MESSENGER; SYNOVIAL MEMBRANE; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84863860601     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2012.0303     Document Type: Article

References (40)

1. Dayer J-M, Krane SM. The interaction of immunocompetent cells and chronic inflammation as exemplified by rheumatoid arthritis. Clin Rheum Dis 1978;4:517-37.
2. Dayer J-M, Beutler B, Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostagladin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985;162:2163-8.
3. Burger D, Rezzonico R, Li JM, et al. Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines. Arthritis Rheum 1998;41(10):1748-59.
4. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003 May 15;423(6937):356-61.
5. Vey, E., Zhang JH, Dayer J-M. IFN-gamma and 1,25(OH)2D3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production, and responsiveness to contact with activated T cells. J Immunol 1992;149:2040-6.
6. Isler P, VeyE, Zhang JH, Dayer J-M. Cell surface glycoproteins expressed on activated human T-cells induce production of interleukin-1beta by monocytic cells: a possible role of CD69. Eur Cytokine Netw 1993;4:15-23.
7. Parry SL, Sebbag M, Feldmann M, Brennan FM. Contact with T cells modulates monocyte IL-10 production: role of T cell membrane TNF-alpha. J Immunol 1997;158(8):3673-81.
8. Brennan FM, Hayes AL, Ciesielski CJ, Green P, Foxwell BM, Feldmann M. Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis. Arthritis Rheum 2002;46(1):31-41.
9. Lacraz S, Isler P, Vey E, Welgus HG, Dayer JM. Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. J Biol Chem 1994;269(35):22027-33.
10. Rezzonico R, Burger D, Dayer JM. Direct contact betweenTlymphocytes and human dermal fibroblasts or synoviocytes down-regulates types I and III collagen production via cell-associated cytokines. J Biol Chem 1998;273(30):18720-8.
11. Miltenburg AM, Lacraz S, Welgus HG, Dayer JM. Immobilized anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts. J Immunol 1995;154(6):2655-67.
12. Vincent C, Nogueira L, Clavel C, Sebbag M, Serre G. Autoantibodies to citrullinated proteins: ACPA. Autoimmunity 2005;38(1):17-24.
13. Masson-Bessiere C, Sebbag M, Durieux JJ, et al. In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol 2000;119(3):544-52.
14. Masson-Bessiere C, Sebbag M, Girbal-Neuhauser E, et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha-and beta-chains of fibrin. J Immunol 2001;166(6):4177-84.
15. Girbal-Neuhauser E, Durieux JJ, Arnaud M, et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 1999 Jan 1;162(1):585-94.
16. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101(1):273-81.
17. Sebbag M, Moinard N, Auger I, et al. Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur J Immunol 2006;36(8):2250-63.
18. Mechin MC, Sebbag M, Arnaud J, et al. Update on peptidylarginine deiminases and deimination in skin physiology and severe human diseases. Int J Cosmet Sci 2007;29(3):147-68.
19. Foulquier C, Sebbag M, Clavel C, et al. Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation. Arthritis Rheum 2007;56(11):3541-53.
20. Molnarfi N, Hyka-Nouspikel N, Gruaz L, Dayer JM, Burger D. The production of IL-1 receptor antagonist in IFN-beta-stimulated human monocytes depends on the activation of phosphatidylinositol 3-kinase but not of STAT1. J Immunol 2005;174(5):2974-80.
21. Gazdar AF, Carney DN, Bunn PA, et al. Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. Blood 1980;55(3):409-17.
22. Lou J, Dayer JM, Grau GE, Burger D. Direct cell/cell contact with stimulated T lymphocytes induces the expression of cell adhesion molecules and cytokines by human brain microvascular endothelial cells. Eur J Immunol;26(12):3107-13.
23. Mentzer SJ, Guyre PM, Burakoff SJ, Faller DV. Spontaneous aggregation as a mechanism for human monocyte purification. Cell Immunol 1986;101(2):312-9.
24. Hyka N, Dayer JM, Modoux C, et al. Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 2001;97(8):2381-9.
25. Molnarfi N, Gruaz L, Dayer JM, Burger D. Opposite effects of IFN beta on cytokine homeostasis in LPS-and T cell contact-activated human monocytes. J Neuroimmunol 2004;146(1-2):76-83.
26. Nachat R, Mechin MC, Takahara H, et al. Peptidylarginine deiminase isoforms 1-3 are expressed in the epidermis and involved in the deimination of K1 and filaggrin. J Invest Dermatol 2005;124(2):384-93.
27. Nakashima K, Hagiwara T, Ishigami A, et al. Molecular characterization of peptidylarginine deiminase in HL-60 cells induced by retinoic acid and 1alpha,25-dihydroxyvitamin D(3). J Biol Chem 1999;274(39):27786-92.
28. Muthukumar T, Dadhania D, Ding R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 2005;353(22):2342-51.
29. Ferrari-Lacraz S, Zanelli E, Neuberg M, et al. Targeting IL-15 receptor-bearing cells with an antagonist mutant IL-15/Fc protein prevents disease development and progression in murine collageninduced arthritis. J Immunol;173(9):5818-26.
30. Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003;25(11):1106-18.
31. Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 2008;118(11):3537-45.
32. Gabay C, Marinova-Mutafchieva L, Williams RO, et al. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis. Arthritis Rheum 2001;44(2):451-62.
33. Smeets TJ, Dayer JM, Kraan MC, et al. The effects of interferon-beta treatment of synovial inflammation and expression of metalloproteinases in patients with rheumatoid arthritis. Arthritis Rheum 2000;43(2):270-4.
34. Palmer G, Mezin F, Juge-Aubry CE, Plater-Zyberk C, Gabay C, Guerne PA. Interferon beta stimulates interleukin 1 receptor antagonist production in human articular chondrocytes and synovial fibroblasts. Ann Rheum Dis 2004;63(1):43-9.
35. Dayer JM, Burger D. Cell-cell interactions and tissue damage in rheumatoid arthritis. Autoimmun Rev 2004;3 Suppl 1:S14-6.
36. Makrygiannakis D, Revu S, Neregard P, et al. Monocytes are essential for inhibition of synovial T-cell glucocorticoid-mediated apoptosis in rheumatoid arthritis. Arthritis Res Ther 2008;10(6):R147.
37. Makrygiannakis D, Revu S, Engstrom M, et al. Local administration of glucocorticoids decrease synovial citrullination in rheumatoid arthritis. Arthritis Res Ther 2012 Jan 27;14(1):R20 (epub).
38. FisherBA, Venables PJ. Inhibiting citrullination in rheumatoid arthritis: taking fuel from the fire. Arthritis Res Ther 2012 Feb 29;14(1):108 (epub).
39. Ribbens C, Dayer JM, Chizzolini C. CD40-CD40 ligand (CD154) engagement is required but may not be sufficient for human T helper 1 cell induction of interleukin-2-or interleukin-15-driven, contactdependent, interleukin-1beta production by monocytes. Immunology 2000;99(2):279-86.
40. Vossenaar ER, Radstake TR, van der Heijden A, et al. Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages. Ann Rheum Dis 2004;63(4):373-81.